Salmonella as an Innovative Therapeutic Antitumor Agent
AbstractLack of specificity of the therapeutic agent is a primary limitation in the treatment of a tumor. The use of preferentially replicating bacteria as therapeutic agents is an innovative approach to tumor treatment. This is based on the observation that certain obligate or facultative anaerobic bacteria are capable of multiplying selectively in tumors and inhibiting their growth. Bacteria have been employed as antitumor agents that are capable of preferentially amplifying within tumors and inhibiting their growth. Moreover, bacteria-derived factors have an immune-stimulation effect. Therefore, bacteria are able to transfer therapeutic genes into the tumor cells using their infective ability. Herein, we introduce the application of bacteria for tumor therapy and focus on Salmonella, which have been widely used for tumor therapy. Salmonella have mainly been applied as gene-delivery vectors, antitumor immune activators and tumor cell death inducers. This study will not only evaluate the therapeutic efficacy of Salmonella for the treatment of tumor but will also elucidate the mechanisms underlying the antitumor activities mediated by Salmonella, which involve host immune responses and cellular molecular responses. View Full-Text
Share & Cite This Article
Chang, W.-W.; Lee, C.-H. Salmonella as an Innovative Therapeutic Antitumor Agent. Int. J. Mol. Sci. 2014, 15, 14546-14554.
Chang W-W, Lee C-H. Salmonella as an Innovative Therapeutic Antitumor Agent. International Journal of Molecular Sciences. 2014; 15(8):14546-14554.Chicago/Turabian Style
Chang, Wen-Wei; Lee, Che-Hsin. 2014. "Salmonella as an Innovative Therapeutic Antitumor Agent." Int. J. Mol. Sci. 15, no. 8: 14546-14554.